FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: European Medicines Agency

Sort
E.g., 2013-05-18
E.g., 2013-05-18
Enter a comma separated list of user names.

Gilead Sciences Incorporated (NASDAQ:GILD) Human immunodeficiency virus (HIV) is a lentivirus that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.

For more information go to http://pennyotcstock.com/?p=17283

Gilead Sciences Incorporated (NASDAQ:GILD) Human immunodeficiency virus (HIV) is a lentivirus that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.

For more information go to http://pennygovernance.com/?p=16540

FREE Daily Stock Alerts From Stock-PR.com

Gilead Sciences Incorporated (NASDAQ:GILD) Human immunodeficiency virus (HIV) is a lentivirus that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.

Gilead Sciences Incorporated (NASDAQ:GILD) Human immunodeficiency virus (HIV) is a lentivirus that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.

For more information go to http://crwepicks.com/?p=18407

The FDA says a Vertex Pharmaceuticals’ (VRTX) hepatitis C drug successfully treats a clear majority of patients in less time than older medicines that have been used for 20 years.

The Food and Drug Administration posted its review of VRTX’s telaprevir ahead of a meeting Thursday where outside experts will vote on the benefits of the drug.

ADVERTISE WITH US